Background Germline pathogenic variants (PVs) in BRCA1/2 genes are associated with breast cancer (BC) risk in both women and men. Multigene panel testing is being increasingly used for BC risk assessment, allowing the identification of PVs in genes other than BRCA1/2. While data on actionable PVs in other cancer susceptibility genes are now available in female BC, reliable data are still lacking in male BC (MBC). This study aimed to provide the patterns, prevalence and risk estimates associated with PVs in non-BRCA1/2 genes for MBC in order to improve BC prevention for male patients. Methods We performed a large case-control study in the Italian population, including 767 BRCA1/2-negative MBCs and 1349 male controls, all screened using a custom 50 cancer gene panel. Results PVs in genes other than BRCA1/2 were significantly more frequent in MBCs compared with controls (4.8% vs 1.8%, respectively) and associated with a threefold increased MBC risk (OR: 3.48, 95% CI: 1.88–6.44; p < 0.0001). PV carriers were more likely to have personal (p = 0.03) and family (p = 0.02) history of cancers, not limited to BC. PALB2 PVs were associated with a sevenfold increased MBC risk (OR: 7.28, 95% CI: 1.17–45.52; p = 0.034), and ATM PVs with a fivefold increased MBC risk (OR: 4.79, 95% CI: 1.12–20.56; p = 0.035). Conclusions This study highlights the role of PALB2 and ATM PVs in MBC susceptibility and provides risk estimates at population level. These data may help in the implementation of multigene panel testing in MBC patients and inform gender-specific BC risk management and decision making for patients and their families.

Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study / Bucalo, Agostino; Conti, Giulia; Valentini, Virginia; Capalbo, Carlo; Bruselles, Alessandro; Tartaglia, Marco; Bonanni, Bernardo; Calistri, Daniele; Coppa, Anna; Cortesi, Laura; Giannini, Giuseppe; Gismondi, Viviana; Manoukian, Siranoush; Manzella, Livia; Montagna, Marco; Peterlongo, Paolo; Radice, Paolo; Russo, Antonio; Tibiletti, Maria Grazia; Turchetti, Daniela; Viel, Alessandra; Zanna, Ines; Palli, Domenico; Silvestri, Valentina; Ottini, Laura. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 188:(2023), pp. 183-191. [10.1016/j.ejca.2023.04.022]

Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study

Bucalo, Agostino;Conti, Giulia;Valentini, Virginia;Capalbo, Carlo;Coppa, Anna;Giannini, Giuseppe;Silvestri, Valentina;Ottini, Laura
2023

Abstract

Background Germline pathogenic variants (PVs) in BRCA1/2 genes are associated with breast cancer (BC) risk in both women and men. Multigene panel testing is being increasingly used for BC risk assessment, allowing the identification of PVs in genes other than BRCA1/2. While data on actionable PVs in other cancer susceptibility genes are now available in female BC, reliable data are still lacking in male BC (MBC). This study aimed to provide the patterns, prevalence and risk estimates associated with PVs in non-BRCA1/2 genes for MBC in order to improve BC prevention for male patients. Methods We performed a large case-control study in the Italian population, including 767 BRCA1/2-negative MBCs and 1349 male controls, all screened using a custom 50 cancer gene panel. Results PVs in genes other than BRCA1/2 were significantly more frequent in MBCs compared with controls (4.8% vs 1.8%, respectively) and associated with a threefold increased MBC risk (OR: 3.48, 95% CI: 1.88–6.44; p < 0.0001). PV carriers were more likely to have personal (p = 0.03) and family (p = 0.02) history of cancers, not limited to BC. PALB2 PVs were associated with a sevenfold increased MBC risk (OR: 7.28, 95% CI: 1.17–45.52; p = 0.034), and ATM PVs with a fivefold increased MBC risk (OR: 4.79, 95% CI: 1.12–20.56; p = 0.035). Conclusions This study highlights the role of PALB2 and ATM PVs in MBC susceptibility and provides risk estimates at population level. These data may help in the implementation of multigene panel testing in MBC patients and inform gender-specific BC risk management and decision making for patients and their families.
2023
Male breast cancer; Multigene panel testing; Case-control study; Pathogenic variants; Breast cancer risk; BRCA1/2; PALB2; ATM; CHEK2
01 Pubblicazione su rivista::01a Articolo in rivista
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study / Bucalo, Agostino; Conti, Giulia; Valentini, Virginia; Capalbo, Carlo; Bruselles, Alessandro; Tartaglia, Marco; Bonanni, Bernardo; Calistri, Daniele; Coppa, Anna; Cortesi, Laura; Giannini, Giuseppe; Gismondi, Viviana; Manoukian, Siranoush; Manzella, Livia; Montagna, Marco; Peterlongo, Paolo; Radice, Paolo; Russo, Antonio; Tibiletti, Maria Grazia; Turchetti, Daniela; Viel, Alessandra; Zanna, Ines; Palli, Domenico; Silvestri, Valentina; Ottini, Laura. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 188:(2023), pp. 183-191. [10.1016/j.ejca.2023.04.022]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1681363
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact